Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy. Demchuk AM, Yue P, Zotova E, Nakamya J, et al. Stroke 2021;52:2096-2105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Demchuk AM, Yue P, Zotova E, Nakamya J, et al. Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy. Stroke 2021;52:2096-2105.
PMID: 33966491